To CANCER IMMUNITY Home Page

Figure 2

ELISPOT assays with B-24 CTL against CMS8 cells pulsed with synthetic peptides. CMS8 cells were pulsed with three Ld-binding peptides, pRL1a, p2Ca and T2H (A). ELISPOT assay of B-24 CTL against different numbers of CMS8 cells pulsed with pRL1a (B).

 

Copyright © 2001 by Akiko Uenaka